These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 9703232

  • 1. The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation.
    Conte JV, Gaine SP, Orens JB, Harris T, Rubin LJ.
    J Heart Lung Transplant; 1998 Jul; 17(7):679-85. PubMed ID: 9703232
    [Abstract] [Full Text] [Related]

  • 2. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
    Cabrol S, Souza R, Jais X, Fadel E, Ali RH, Humbert M, Dartevelle P, Simonneau G, Sitbon O.
    J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T, Ozawa Y, Nakayama T, Matsuura H, Hashiguchi R, Matsuo N, Muto H, Yamazaki J, Morishita T, Saito T.
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [Abstract] [Full Text] [Related]

  • 9. Continuous intravenous epoprostenol in pulmonary hypertension: the Israel experience.
    Bendayan D, Fink G, Aravot D, Ygla M, Bendov I, Bliden L, Nir A, Kramer MR.
    Isr Med Assoc J; 2002 Apr; 4(4):255-8. PubMed ID: 12001697
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pulmonary arterial hypertension in the pediatric age.
    Donti A, Formigari R, Ragni L, Manes A, Galiè N, Picchio FM.
    J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):72-7. PubMed ID: 17255821
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
    Sitbon O, Humbert M, Jaïs X, Ioos V, Hamid AM, Provencher S, Garcia G, Parent F, Hervé P, Simonneau G.
    Circulation; 2005 Jun 14; 111(23):3105-11. PubMed ID: 15939821
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension.
    Krowka MJ, Frantz RP, McGoon MD, Severson C, Plevak DJ, Wiesner RH.
    Hepatology; 1999 Sep 14; 30(3):641-8. PubMed ID: 10462369
    [Abstract] [Full Text] [Related]

  • 18. Survival of patients with idiopathic pulmonary arterial hypertension after listing for transplantation: impact of iloprost and bosentan treatment.
    Dandel M, Lehmkuhl HB, Mulahasanovic S, Weng Y, Kemper D, Grauhan O, Knosalla C, Hetzer R.
    J Heart Lung Transplant; 2007 Sep 14; 26(9):898-906. PubMed ID: 17845928
    [Abstract] [Full Text] [Related]

  • 19. Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesions.
    Scelsi L, Ghio S, Campana C, D'Armini AM, Serio A, Klersy C, Piovella F, Viganò M, Tavazzi L.
    Ital Heart J; 2004 Aug 14; 5(8):618-23. PubMed ID: 15554033
    [Abstract] [Full Text] [Related]

  • 20. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV.
    Srp Arh Celok Lek; 1999 Aug 14; 127(7-8):249-53. PubMed ID: 10624398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.